A breast cancer survivor says she is challenging a patent claim on cancer genes because she does not want biotech companies to own human material.
A landmark case challenging the ownership of breast and ovarian cancer genes is being heard in the Federal Court in Sydney today.
Law firm Maurice Blackburn claims four biotech companies do not have the right to patent a set of human cancer genes — via redwolf.newsvine.com
Share this Story